Aldo-keto reductase family 1 member C3 is a key steroidogenic enzyme that in humans is encoded by the AKR1C3gene.
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14.
^Khanna M, Qin KN, Wang RW, Cheng KC (Sep 1995). "Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases". J Biol Chem270 (34): 20162–8. doi:10.1074/jbc.270.34.20162. PMID7650035.
^Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S (Feb 1999). "Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity". J Biochem124 (5): 940–6. doi:10.1093/oxfordjournals.jbchem.a022211. PMID9792917.
Lin SX, Shi R, Qiu W et al. (2006). "Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5". Mol. Cell. Endocrinol.248 (1–2): 38–46. doi:10.1016/j.mce.2005.11.035. PMID16480815.
Khanna M, Qin KN, Cheng KC (1995). "Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans". J. Steroid Biochem. Mol. Biol.53 (1–6): 41–6. doi:10.1016/0960-0760(95)00019-V. PMID7626489.
Nagase T, Miyajima N, Tanaka A et al. (1995). "Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1". DNA Res.2 (1): 37–43. doi:10.1093/dnares/2.1.37. PMID7788527.
Khanna M, Qin KN, Klisak I et al. (1995). "Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization". Genomics25 (2): 588–90. doi:10.1016/0888-7543(95)80066-U. PMID7789999.
Qin KN, New MI, Cheng KC (1994). "Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase". J. Steroid Biochem. Mol. Biol.46 (6): 673–9. doi:10.1016/0960-0760(93)90308-J. PMID8274401.
Bennett MJ, Schlegel BP, Jez JM et al. (1996). "Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+". Biochemistry35 (33): 10702–11. doi:10.1021/bi9604688. PMID8718859.
Lin HK, Jez JM, Schlegel BP et al. (1998). "Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution". Mol. Endocrinol.11 (13): 1971–84. doi:10.1210/me.11.13.1971. PMID9415401.
Mills KI, Gilkes AF, Sweeney M et al. (1999). "Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells". FEBS Lett.440 (1–2): 158–62. doi:10.1016/S0014-5793(98)01435-5. PMID9862446.
Dufort I, Rheault P, Huang XF et al. (1999). "Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase". Endocrinology140 (2): 568–74. doi:10.1210/en.140.2.568. PMID9927279.
Rheault P, Dufort I, Soucy P, Luu-The V (1999). "Assignment of HSD17B5 encoding type 5 17 beta-hydroxysteroid dehydrogenase to human chromosome bands 10p15→p14 and mouse chromosome 13 region A2 by in situ hybridization: identification of a new syntenic relationship". Cytogenet. Cell Genet.84 (3–4): 241–2. doi:10.1159/000015267. PMID10393440.
Penning TM, Burczynski ME, Jez JM et al. (2001). "Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3)". Mol. Cell. Endocrinol.171 (1–2): 137–49. doi:10.1016/S0303-7207(00)00426-3. PMID11165022.